Anti-Parietal Antibodies (APA)

The anti-parietal antibodies (APA) test, offered at IntroLab in Belgrade, is a specialized diagnostic test designed to identify specific autoantibodies in a blood sample. These antibodies, known as anti-parietal antibodies, target the cells of the stomach lining and are often indicators of pernicious anemia or other autoimmune disorders.

What are anti-parietal antibodies (APA)?

Anti-parietal antibodies (APA) are specific autoantibodies that target the parietal cells of the stomach, which are responsible for producing intrinsic factor, essential for the absorption of vitamin B12. Their presence can be linked to certain autoimmune diseases, such as pernicious anemia.

When and who should get tested for anti-parietal antibodies?

Testing for anti-parietal antibodies is especially relevant for individuals suspected of having pernicious anemia or other autoimmune diseases affecting the stomach. This test can also be used to monitor the progression of these diseases and the effectiveness of treatments.

The test is recommended if you have symptoms that may indicate these conditions, such as:

• Fatigue
• Weakness
• Lack of coordination
• Gastrointestinal problems
• Changes in the tongue and skin

How are the results interpreted?

Elevated levels of anti-parietal antibodies may indicate the presence of autoimmune diseases, while lower levels are usually not clinically significant.

Specifics and limitations of the test

While the presence of anti-parietal antibodies is often associated with pernicious anemia, this test alone cannot confirm the diagnosis. A positive result should be interpreted in conjunction with the patient’s symptoms, clinical findings, and other laboratory tests.